Global and China Human Rotavirus Vaccine Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Human Rotavirus Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bharat Biotech

    • GlaxoSmithKline

    • Merck

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Rotarix

    • RotaTeq

    • Rotavac

    • Rotavin-M1

    • Lanzhou lamb

    • Others

    Application:

    • Hospitals & Clinics

    • Academic And Research

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Human Rotavirus Vaccine Industry Overview

      • 1.1.1 Human Rotavirus Vaccine Market Scope and Market Segments

      • 1.1.2 Human Rotavirus Vaccine Industry Characteristics

      • 1.1.3 Global and China Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Human Rotavirus Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Human Rotavirus Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Rotarix

      • 1.2.2 RotaTeq

      • 1.2.3 Rotavac

      • 1.2.4 Rotavin-M1

      • 1.2.5 Lanzhou lamb

      • 1.2.6 Others

    • 1.3 Global Human Rotavirus Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals & Clinics

      • 1.3.2 Academic And Research

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Human Rotavirus Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Human Rotavirus Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Human Rotavirus Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Human Rotavirus Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Human Rotavirus Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Human Rotavirus Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Human Rotavirus Vaccine Industry PEST Analysis

    • 2.3 Human Rotavirus Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Human Rotavirus Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Human Rotavirus Vaccine Industry

    Chapter 3 Global and China Human Rotavirus Vaccine Market, by Manufacturer

    • 3.1 Global and China Human Rotavirus Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Human Rotavirus Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Human Rotavirus Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Human Rotavirus Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Human Rotavirus Vaccine Market Top 3 Players

    Chapter 4 Global and China Human Rotavirus Vaccine Market, by Type (2017-2028)

    • 4.1 Human Rotavirus Vaccine Market Trend, by Type

    • 4.2 Global Human Rotavirus Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Human Rotavirus Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Human Rotavirus Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Human Rotavirus Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Human Rotavirus Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Human Rotavirus Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Human Rotavirus Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Human Rotavirus Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Human Rotavirus Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Human Rotavirus Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Human Rotavirus Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Human Rotavirus Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Human Rotavirus Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Human Rotavirus Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Human Rotavirus Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Human Rotavirus Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Human Rotavirus Vaccine Market Analysis

    • 7.1 North America Human Rotavirus Vaccine Market, by Type

    • 7.2 North America Human Rotavirus Vaccine Market, by Application

    • 7.3 North America Human Rotavirus Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Human Rotavirus Vaccine Market Analysis

    • 8.1 Europe Human Rotavirus Vaccine Market, by Type

    • 8.2 Europe Human Rotavirus Vaccine Market, by Application

    • 8.3 Europe Human Rotavirus Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Human Rotavirus Vaccine Market Analysis

    • 9.1 APAC Human Rotavirus Vaccine Market, by Type

    • 9.2 APAC Human Rotavirus Vaccine Market, by Application

    • 9.3 APAC Human Rotavirus Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Human Rotavirus Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Human Rotavirus Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Human Rotavirus Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Human Rotavirus Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Human Rotavirus Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Human Rotavirus Vaccine Company Profiles

      • 11.1 Bharat Biotech

        • 11.1.1 Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bharat Biotech Human Rotavirus Vaccine Product Profiles, Application and Specification

        • 11.1.3 Bharat Biotech Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GlaxoSmithKline

        • 11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GlaxoSmithKline Human Rotavirus Vaccine Product Profiles, Application and Specification

        • 11.2.3 GlaxoSmithKline Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Merck

        • 11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Merck Human Rotavirus Vaccine Product Profiles, Application and Specification

        • 11.3.3 Merck Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Human Rotavirus Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Human Rotavirus Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Human Rotavirus Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Human Rotavirus Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Human Rotavirus Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Rotarix (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of RotaTeq (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Rotavac (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Rotavin-M1 (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Lanzhou lamb (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Hospitals & Clinics (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Academic And Research (2017-2028)

    • Figure Global Human Rotavirus Vaccine Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Human Rotavirus Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Human Rotavirus Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Human Rotavirus Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Human Rotavirus Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Human Rotavirus Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Human Rotavirus Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Human Rotavirus Vaccine Market Share, by Manufacturer in 2022

    • Table Global Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Value, by Type (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Human Rotavirus Vaccine Price Trend, by Type (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Value, by Type (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Human Rotavirus Vaccine Price Trend, by Type (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Value, by Application (2017-2028)

    • Table Global Human Rotavirus Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Human Rotavirus Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Value, by Application (2017-2028)

    • Table China Human Rotavirus Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Human Rotavirus Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Human Rotavirus Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Human Rotavirus Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Human Rotavirus Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bharat Biotech Product Profiles, Application and Specification

    • Table Bharat Biotech Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Human Rotavirus Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.